Key facts
- This page summarizes Eric Semler's Form 4 filing for Semler Scientific, Inc. (SMLR).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 07 Jan 2025, 17:30.
Eric Semler - 06 Jan 2025 Form 4 Insider Report for Semler Scientific, Inc. (SMLR)
- Reporting relationship
- Director
- Issuer ticker
- SMLR
- Reported as of
- 06 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jan 2025, 17:30:33 UTC
- Prior SEC filing
- 17 Dec 2024
- Next SEC filing
- 05 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Renae Cormier, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Semler filed Form 4 for Semler Scientific, Inc. (SMLR) on 07 Jan 2025.
Change
- Previous filing in this sequence was filed on 17 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SMLR
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +8,000
- Change %
- Price
- $0.000000
- Shares after
- 8,000
- Date
- 06 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,000
- Exercise price
- $58.94
- Footnotes
- F1
SMLR
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- Price
- $0.000000
- Shares after
- 150,000
- Date
- 06 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $58.94
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares underlying the option shall vest and become exercisable as follows: 1/12th of the underlying shares shall vest on the grant date, following which 1/12th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the first anniversary of the grant date.
Footnote F2
The shares underlying the option shall vest and become exercisable as follows: 1/24th of the underlying shares shall vest on the grant date, following which 1/24th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the second anniversary of the grant date.